Pd(II)-based low-symmetry coordination cages possessing anisotropic cavities are of great interest. The common strategies employed to achieve such cages utilize either more than one type of symmetrical ligands (e.g., L, L etc.) or only one type of unsymmetrical ligand (e.g., L). To significantly enhance the anisotropy, we have designed two unsymmetrical bidentate ligands i.e., L and L, aiming at a low-symmetry PdL L -type cage. It was accomplished by high-fidelity integrative self-sorting of two different low-symmetry cages having PdL and PdL -type architectures (homoleptic complexes of the designed ligands). Structural constraints and geometry complementarity in the ligand design drive the non-statistical exclusive self-assembly of the PdL L -type cage. By taking advantage of the complemental geometries between ligands, a low-symmetry PdL L -type cage was also obtained. Heteromeric completive self-sorting of three homoleptic assemblies (PdL , PdL and PdL -type cages) into an exclusive mixture of PdL L and PdL L -type mixed ligated assemblies was demonstrated through cage-to-cage transformations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/anie.202410219 | DOI Listing |
J Cosmet Dermatol
December 2024
Consultant Dermatologist, Aalborg University, Aalborg, Denmark.
Objective: We aimed to document the treatment outcomes of African patients treated with low-intensity electrodesiccation for DPN's. Other treatment options for DPN's include snip excision, light curettage, cryotherapy, and lasers devices such as PDL, Nd: YAG, KTP, and CO2, which are generally unsafe for darker skin types and come with high costs.
Methods: Nonprobability convenience sampling of patient records was used to extract retrospective data on demographics and treatment outcomes according to the inclusion criteria.
Cochrane Database Syst Rev
November 2024
Cancer Theme, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
This is a protocol for a Cochrane Review (prognosis). The objectives are as follows: Primary objectives To identify and estimate the prognostic value of molecular biomarkers as predictors of pathological complete response to neoadjuvant chemoradiotherapy in people with locally advanced rectal cancer. summarises the review question in population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format.
View Article and Find Full Text PDFJ Clin Med
November 2024
Fundación Santa Fe de Bogotá Centro de Cuidado Clínico de Cáncer de Pulmón, Bogotá 110111, Colombia.
This study aimed to provide a comprehensive analysis of 56 patients admitted to the Lung Cancer Clinical Care Center (C3) at Fundación Santa Fe de Bogotá (FSFB) between 2 May 2022 and 22 April 2024. The focus was on demographic characteristics, smoking history, comorbidities, lung cancer types, TNM classification, treatment modalities, and outcomes. This observational case series study reviewed medical records and included patients over 18 years with a confirmed diagnosis of non-small cell lung cancer (NSCLC).
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
December 2024
Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China. Electronic address:
Background: Hemoporfin-mediated photodynamic therapy (Hemoporfin-PDT) is considered a safe and effective treatment for port-wine stains (PWS). This study aims to investigate the influence of prior pulse dye laser (PDL) treatments history on the effectiveness of Hemoporfin-PDT in young children aged 1-3 years with PWS.
Methods: Data was gathered for individuals with PWS aged 1-3 years who received two or more Hemoporfin-PDT treatments.
Cureus
October 2024
Respiratory Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, IND.
Background: The prevalence of programmed cell death ligand-1(PD-L1) expression in non-small cell lung cancer (NSCLC) within unselected populations remains a research topic, though PD-L1 expression is important in guiding treatment decisions.
Objectives: The study objective was to ascertain the prevalence of PD-L1 expression in patients of NSCLC and its association with clinicopathological characteristics and other gene mutations.
Methods: Samples from patients with NSCLCs were analyzed in the study to determine the expression of PD-L1 through immunohistochemistry (IHC) using rabbit anti-human PDL-1/CD274 monoclonal antibody.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!